Indiana CTSI congratulates Eli Lilly and Company on 150 years of innovation and impact

The Indiana Clinical and Translational Sciences Institute (CTSI) congratulates Eli Lilly and Company on the milestone celebration of its 150th anniversary. Founded in Indianapolis in 1876, Eli Lilly has grown into a global leader in pharmaceutical innovation while maintaining deep roots in Indiana and a lasting commitment to improving health around the world.

Sharon Moe, MD, and Sarah Wiehe, MD, MPH, co-directors of the Indiana CTSI, said the institute is proud to partner with Eli Lilly in advancing clinical and translational research that accelerates the journey from scientific discovery to real-world patient benefit. Since the Indiana CTSI was founded in 2008, the two organizations have worked together to strengthen Indiana’s life sciences ecosystem, support researchers and clinicians, and foster innovative approaches to preventing and treating disease.

“Eli Lilly’s 150-year legacy is marked by scientific excellence, bold innovation, and a clear commitment to improving people’s lives,” said Moe. “We are grateful for our longstanding partnership and the shared belief that collaboration is essential to translating discoveries into better health outcomes. The Indiana CTSI is excited to continue working alongside Eli Lilly on new ideas, technologies, and discoveries that will shape the next generation of medicine.”

As Eli Lilly commemorates this historic anniversary, the Indiana CTSI celebrates the company’s achievements and the collaborative spirit that continues to drive progress. Together, the Indiana CTSI and Eli Lilly remain focused on advancing science, supporting researchers, and improving health for communities everywhere.